Retinal Angiomatous Proliferation
📧 Sign up to get email alerts when something new happens for Retinal Angiomatous Proliferation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial [Phase 2]
Phase 2 BELIEVE-VHL trial is assessing real-world effectiveness and pharmacogenetics of belzutifan in Von Hippel-Lindau syndrome; recruitmen…
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: Treat-and-extend Using Aflibercept for Type 3 Neovascularization [Phase 4]
Phase 4 clinical trial evaluating treat-and-extend using aflibercept for retinal angiomatous proliferation.
-
CLINICAL_TRIALS research · 2012-10-25Clinical Trial Update: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy [Phase 1, Phase 2]
Phase 1/2 clinical trial update on treatments for exudative and vasogenic chorioretinal diseases including AMD variants and other CNV-relate…
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration [Phase 1, Phase 2]
The study completed Phase 1/2 evaluating Lucentis (ranibizumab) for retinal angiomatous proliferation secondary to age-related macular degen…